Global Industrial Hemp in Medical Market Size By Type (Cannabinoid Groups, Non-Cannabinoid Groups), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

lobal Industrial Hemp in Medical Market Report Description

The Global Industrial Hemp in Medical Market was valued at USD 1.8 billion in 2023 and is projected to reach USD 5.4 billion by 2031, growing at a CAGR of 14.6% during the forecast period from 2023 to 2031. The increasing legalization of hemp-derived products for medical use, rising consumer awareness about its therapeutic benefits, and ongoing research into cannabinoid-based treatments are fueling market expansion. Industrial hemp, rich in cannabidiol (CBD), is being increasingly integrated into pharmaceuticals, dietary supplements, and personal care products due to its anti-inflammatory, analgesic, and neuroprotective properties.

Drivers:

1. Legalization and Regulatory Support:

Governments across North America, Europe, and parts of Asia are legalizing the cultivation and use of hemp-derived products, encouraging pharmaceutical companies and medical researchers to invest in CBD-based treatments.

2. Rise in Chronic Conditions and Pain Management:

The growing prevalence of chronic pain, anxiety, and neurological disorders has led to increased adoption of hemp-based medical formulations as alternative therapies, supporting market demand.

3. Research & Innovation in Cannabinoid Therapy:

Ongoing clinical trials and scientific studies validating the efficacy of cannabidiol (CBD) and other non-psychoactive compounds are propelling product development and medical usage of industrial hemp.

Restraints:

1. Regulatory Ambiguity in Developing Regions:

Inconsistent or underdeveloped regulations in many emerging economies continue to hinder market penetration and the commercialization of hemp-based medical products.

2. Limited Clinical Validation:

Although growing, the clinical evidence for many hemp-based medical claims remains insufficient for large-scale medical acceptance, posing a challenge for product approval and adoption.

Opportunity:

1. Pharmaceutical and Nutraceutical Integration:

The incorporation of hemp-derived compounds into over-the-counter and prescription medications opens lucrative growth avenues, particularly in pain management, epilepsy, and mental health.

2. Expanding Geriatric Population:

An aging population with rising incidences of arthritis, insomnia, and neurodegenerative disorders is expected to create sustained demand for hemp-based therapeutic solutions.

Market by System Type Insights:

By system type, the Cannabidiol (CBD) Extracts segment held the largest market share in 2023. CBD’s wide acceptance in medical formulations, combined with its non-intoxicating nature and broad therapeutic profile, drives its dominance. Meanwhile, Isolate Extracts are gaining traction for applications requiring high-purity compounds, particularly in pharmaceutical-grade solutions.

Market by End-use Insights:

The Pharmaceutical segment was the largest revenue contributor in 2023, driven by growing R&D activities and drug formulations based on CBD and other cannabinoids. The Nutraceuticals & Dietary Supplements segment is also expanding rapidly, fueled by demand for wellness-focused medical interventions that promote holistic healing.

Market by Regional Insights:

North America dominated the global market in 2023, led by the U.S., where legalization, R&D activity, and consumer awareness are highly developed. However, Europe is emerging as a high-growth region, particularly due to regulatory harmonization and the growing demand for natural medical therapies. Asia-Pacific is anticipated to witness rapid growth due to rising awareness and gradual regulatory improvements in countries like China and India.

Competitive Scenario:

Key players in the Global Industrial Hemp in Medical Market include:

Canopy Growth Corporation

Aurora Cannabis Inc.

GW Pharmaceuticals plc

CV Sciences, Inc.

Tilray Brands, Inc.

Medical Marijuana, Inc.

Elixinol Global Limited

Charlotte’s Web Holdings, Inc.

These companies are investing in clinical research, forming strategic partnerships, and expanding production capabilities to strengthen their presence in the medical hemp sector.

Scope of Work – Global Industrial Hemp in Medical Market

Key Market Developments:

2023: Charlotte’s Web launched a new line of CBD-based medical supplements targeting neurological disorders and anxiety.

2024: GW Pharmaceuticals received extended approval for its hemp-derived epilepsy medication across multiple EU countries.

2025: Aurora Cannabis announced a partnership with a U.S. university to develop hemp-based anti-inflammatory therapies for geriatric patients.

FAQs:

1) What is the current market size of the Global Industrial Hemp in Medical Market?

The market was valued at USD 1.8 billion in 2023.

2) What is the major growth driver of the Global Industrial Hemp in Medical Market?

The key driver is the increasing legalization of hemp for medical use and rising demand for cannabinoid-based therapies.

3) Which is the largest region during the forecast period in the Global Industrial Hemp in Medical Market?

North America holds the largest market share due to favorable regulation and robust R&D.

4) Which segment accounted for the largest market share in Global Industrial Hemp in Medical Market?

The Cannabidiol (CBD) Extracts segment led the market in 2023.

5) Who are the key market players in the Global Industrial Hemp in Medical Market?

Major players include Canopy Growth, Aurora Cannabis, GW Pharmaceuticals, and Tilray Brands, among others.

Let me know if you'd like a downloadable version or visuals added.